Hepatitis B future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) No edit summary |
m Bot: Removing from Primary care |
||
| (8 intermediate revisions by 4 users not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Currently, new forms of treatment | Currently, new forms of treatment (such as the combination therapy of [[interferon-α]] with [[lamivudine]] for patients who failed [[interferon-α]] monotherapy) are under investigation.<ref name=WHO1>{{cite web | title = Hepatitis B | url = http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/index3.html }}</ref> Future studies and monitoring are required to evaluate the [[genome|genotypic]] resistance of [[HBV]] to [[nucleoside]] and [[nucleotide]] therapy.<ref name="pmid21199523">{{cite journal| author=Lin CL, Kao JH| title=The clinical implications of hepatitis B virus genotype: Recent advances. | journal=J Gastroenterol Hepatol | year= 2011 | volume= 26 Suppl 1 | issue= | pages= 123-30 | pmid=21199523 | doi=10.1111/j.1440-1746.2010.06541.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21199523 }} </ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category: | [[Category:FinalQCRequired]] | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Hepatology]] | |||
Latest revision as of 22:04, 29 July 2020
|
Hepatitis B |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatitis B future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Hepatitis B future or investigational therapies |
|
Risk calculators and risk factors for Hepatitis B future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
Currently, new forms of treatment (such as the combination therapy of interferon-α with lamivudine for patients who failed interferon-α monotherapy) are under investigation.[1] Future studies and monitoring are required to evaluate the genotypic resistance of HBV to nucleoside and nucleotide therapy.[2]
References
- ↑ "Hepatitis B".
- ↑ Lin CL, Kao JH (2011). "The clinical implications of hepatitis B virus genotype: Recent advances". J Gastroenterol Hepatol. 26 Suppl 1: 123–30. doi:10.1111/j.1440-1746.2010.06541.x. PMID 21199523.